永昕

-0.45 (-1.93%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

22.90242成交張數–本益比3.37股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	33	14	57.1%	0.61	6.80	-24.1%	-11.8%	1.1	1.1
2026Q1	33	15	55.5%	0.62	7.17	-25.8%	-13.1%	-0.3	-1.2
2025Q4	33	16	51.0%	0.70	7.72	-24.8%	-13.5%	0.9	0.7
2025Q3	33	16	50.7%	0.75	7.93	-25.7%	-14.1%	-0.5	-0.7
2025Q2	32	18	45.0%	0.84	8.53	-24.8%	-14.5%	-0.8	-0.5
2025Q1	33	19	43.2%	0.92	9.16	-21.9%	-13.6%	0.1	-0.7
2024Q4	34	20	39.9%	1.11	9.77	-20.9%	-13.1%	-0.6	-1.0
2024Q3	35	21	39.7%	1.29	10.15	-22.8%	-14.6%	0.1	-0.5
2024Q2	36	22	38.6%	1.54	10.82	-20.7%	-13.6%	0.2	-0.1
2024Q1	34	23	32.4%	1.47	11.27	-22.3%	-15.0%	-1.6	-3.6
2023Q4	38	24	35.1%	1.46	11.89	-24.6%	-16.6%	-0.4	-1.3
2023Q3	38	26	32.4%	2.11	12.63	-31.5%	-19.5%	0.1	-0.4
2023Q2	39	27	30.7%	2.47	13.22	-33.6%	-21.4%	-0.0	-1.2
2023Q1	43	29	32.5%	2.47	13.98	-29.7%	-18.6%	-0.9	-1.3
2022Q4	45	31	30.3%	3.03	15.13	-18.1%	-11.9%	-0.6	-1.0
2022Q3	35	19	44.4%	1.48	12.38	-16.9%	-10.3%	-0.9	-2.2
2022Q2	32	18	43.3%	1.51	11.84	-12.1%	-8.1%	-0.6	-1.5
2022Q1	34	19	43.5%	1.29	12.63	-9.2%	-6.2%	0.6	-0.6
2021Q4	31	19	39.3%	1.66	12.43	-5.8%	-3.7%	-0.0	-1.7
2021Q3	29	19	32.0%	1.25	12.70	-2.9%	-2.1%	-1.1	-2.3
2021Q2	26	20	20.4%	2.56	13.25	1.2%	0.9%	-0.7	-1.6
2021Q1	26	21	19.1%	3.43	13.70	10.6%	8.2%	0.4	-0.1
2020Q4	18	12	30.9%	1.36	9.45	2.7%	2.0%	0.5	0.3
2020Q3	16	12	22.6%	1.87	9.64	0.1%	0.0%	0.2	-0.9
2020Q2	15	12	17.8%	2.65	9.66	-6.3%	-5.0%	0.5	0.4
2020Q1	15	10	28.3%	1.73	8.16	-16.4%	-11.8%	0.5	0.4
2019Q4	14	11	21.7%	2.13	8.61	-21.7%	-17.3%	-0.8	-1.0
2019Q3	15	11	22.2%	2.18	8.89	-25.0%	-20.3%	0.3	0.3
2019Q2	16	13	23.3%	3.34	9.78	-20.1%	-16.4%	-0.2	-0.2
2019Q1	17	12	27.7%	2.64	9.69	-21.9%	-17.3%	-0.7	-1.9
2018Q4	11	9	18.9%	2.59	8.25	-26.8%	-22.6%	-0.6	-1.0
2018Q3	12	10	14.2%	4.23	9.16	-26.2%	-23.7%	-0.1	-0.2
2018Q2	12	10	11.3%	6.31	9.34	-19.2%	-17.5%	-0.6	-0.6
2018Q1	12	11	10.9%	7.12	9.87	-15.8%	-14.6%	-0.6	-0.6
2017Q4	13	11	12.9%	5.99	10.20	-15.3%	-13.9%	0.0	-0.1
2017Q3	13	13	5.4%	11.52	11.20	-7.4%	-7.1%	0.2	-0.1
2017Q2	13	12	6.2%	10.15	10.99	-11.0%	-10.2%	-0.2	-0.3
2017Q1	13	12	4.5%	14.24	11.15	-13.0%	-12.4%	-0.5	-0.6
2016Q4	14	13	5.3%	13.29	11.75	–	–	-0.0	0.1
2016Q3	14	13	4.3%	16.24	11.91	–	–	-0.4	-0.8